Curis Lifesciences IPO Details
The Curis Lifesciences IPO is a book build issue with a total issue size of ₹27.52 cr Curis Lifesciences IPO opened for subscription on Nov 07, 2025 and closed on Nov 11, 2025. Curis Lifesciences IPO is set price band at ₹120 to ₹128 per share, with a lot size of 1000 shares. Minimum investment for Retail investors was ₹256,000.00 (at the upper price band) to apply for one lot.
The basis of allotment got finalized on Nov 12, 2025, and listed on the NSE on Nov 14, 2025.
MUFG Intime India Private Limited has been appointed as the registrar. Swastika Investmart Ltd are the Book Running Lead Manager for the issue.
Before investing in the Curis Lifesciences IPO, investors should review the company's financial performance, business objectives, and risk factors mentioned in the offer documents and apply before the subscription window closes.
- Price Band
- ₹ 120 – 128
- Lot Size
- 1000
- Issue Size
- ₹27.52 Cr
- Minimum Investment
- ₹256000 (2000 Shares)
- Listing Date
- 14 November 2025
Current GMP
₹9 (+7.03%)
*Info is indicative. Not an Investment Advice. Grey market trading is unregulated.
About Curis Lifesciences Limited
Curis Lifesciences Limited
Incorporation Year: 2010
Headquarters: Sanand, Gujarat, India
Overview:
Curis Lifesciences Limited is a pharmaceutical company engaged in the development, manufacturing, and distribution of a wide range of high-quality pharmaceutical products. The company operates globally and domestically, offering services on a loan license, contract manufacturing, and own brand marketing basis.
Operations:
Curis Lifesciences manufactures pharmaceutical formulations for over 100 corporate clients under loan license and contract manufacturing arrangements. In addition, the company markets its own brands in Yemen and Kenya, serving two international clients under its brand portfolio.
Product Portfolio:
- General pharmaceutical tablets and capsules
- Oral liquids
- External preparations (topical formulations)
- Sterile ophthalmic ointments
Manufacturing Facility:
The company operates a state-of-the-art manufacturing facility located in Sanand, Gujarat, equipped with advanced technology and robust quality assurance systems. The facility complies with stringent regulatory and quality control standards to ensure the safety, efficacy, and reliability of all products.
Workforce:
As of July 31, 2025, Curis Lifesciences Limited employs 95 permanent staff members, comprising skilled professionals across manufacturing, quality assurance, research, and administrative functions.
Curis Lifesciences IPO Promoters
- Mr. Dharmesh Dashrathbhai Patel
- Mr. Siddhant Jayantibhai Pawasia
- Mr. Piyush Gordhanbhai Antala
- Mr. Jaimik Mansukhbhai Patel
Promoters Holding
Holding Pre Issue
92.68%
Holding Post Issue
68.03%
Curis Lifesciences IPO Objective
The Company Curis Lifesciences IPO proposes to utilise the Net Proceeds from the Issue towards the following objects.
- Capital Expenditure towards Upgradation/Improvement of our existing Manufacturing Facilities
- Capital Expenditure towards Construction of a Storage Facility
- Pre-payment/Repayment of outstanding Secured Loans
- Product Registrations in other countries
- Funding our Working Capital Requirements
- General Corporate Purposes
Address / Contact Info
Curis Lifesciences Ltd.
PF-23, GIDC Sanand - II,
Industrial Estate,Sanand
Ahmedabad, Gujarat, 382110
Phone: +91 99045 22543
Email: cs@curisls.com
Website: https://curisls.com/
IPO Snapshot
Book Running Lead Managers
- Swastika Investmart Ltd
Disclaimer: This data is for informational purposes only and does not constitute investment advice. Figures shown are illustrative sample data.
Frequently Asked Questions
Everything you need to know before applying to an IPO.
Curis Lifesciences IPO is a Book-building IPO with a total issue size of ₹27.52 crore. The Curis Lifesciences IPO price band is ₹120 to 128 per share. The Curis Lifesciences IPO subscription opens on Fri, Nov 7, 2025, and closes on Tue, Nov 11, 2025. The Curis Lifesciences IPO will be listed on the NSE. MUFG Intime India Private Limited is the registrar for the Curis Lifesciences IPO.
The Curis Lifesciences IPO opens on Fri, Nov 7, 2025 and closes on Tue, Nov 11, 2025
Curis Lifesciences IPO Price Band is ₹120 to 128 per share.
Curis Lifesciences IPO lot size is 1000 shares, Retail investors need a minimum investment of ₹256000 based on the upper price band
The minimum investment for Curis Lifesciences IPO is ₹256000, based on one lot of 1000 shares at the upper price band of ₹128 per share.
Investors can apply for the Curis Lifesciences IPO through the ASBA (Application Supported by Blocked Amount) facility offered by their bank or through UPI using a SEBI-registered broker or trading app. Select the desired lot size, enter your bid within the price band, and submit the application before Tue, Nov 11, 2025. The application amount remains blocked until the Curis Lifesciences IPO allotment is finalized.
Curis Lifesciences IPO issue size is ₹27.52 crores.
Curis Lifesciences IPO allotment date is Wed, Jul 1, 2026.
The registrar for Curis Lifesciences IPO is MUFG Intime India Private Limited. Investors can go to MUFG Intime India Private Limited website to check Curis Lifesciences IPO allotment status, refund processing, and other IPO-related information.
The Curis Lifesciences IPO GMP (Grey Market Premium) is ₹9 as of Fri, Nov 14, 2025. Based on the upper price band of ₹128 per share, the estimated Curis Lifesciences IPO listing price is ₹137, indicating a potential listing gain of approximately 0% over the issue price.